Giant Biogene Holding Co., Ltd (2367.HK) announced a profit for full year that Dropped, from last year
The company's earnings came in at RMB1.915 billion, or RMB1.81 per share. This compares with RMB2.062 billion, or RMB2.06 per share, last year.
The company's revenue for the period fell 0.4% to RMB5.519 billion from RMB5.539 billion last year.
Giant Biogene Holding Co., Ltd earnings at a glance (GAAP) :
-Earnings: RMB1.915 Bln. vs. RMB2.062 Bln. last year.-EPS: RMB1.81 vs. RMB2.06 last year.-Revenue: RMB5.519 Bln vs. RMB5.539 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.